Insufficient scRNA-seq data for expression of TGFBR3L at single-cell level.
Insufficient scRNA-seq data for expression of TGFBR3L at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 90% | 69.41 | 204 / 226 | 63% | 2.40 | 256 / 406 |
| brain | 94% | 141.81 | 2490 / 2642 | 28% | 0.61 | 197 / 705 |
| uterus | 95% | 74.16 | 162 / 170 | 22% | 0.70 | 100 / 459 |
| prostate | 90% | 46.62 | 220 / 245 | 19% | 0.30 | 93 / 502 |
| kidney | 84% | 43.30 | 75 / 89 | 21% | 0.46 | 185 / 901 |
| ureter | 0% | 0 | 0 / 0 | 100% | 1.72 | 1 / 1 |
| skin | 78% | 27.11 | 1405 / 1809 | 20% | 0.37 | 93 / 472 |
| esophagus | 57% | 28.92 | 828 / 1445 | 37% | 1.63 | 67 / 183 |
| intestine | 77% | 25.25 | 741 / 966 | 14% | 0.40 | 74 / 527 |
| heart | 83% | 43.27 | 715 / 861 | 0% | 0 | 0 / 0 |
| adrenal gland | 18% | 8.53 | 47 / 258 | 59% | 4.72 | 135 / 230 |
| bladder | 57% | 25.67 | 12 / 21 | 14% | 0.34 | 69 / 504 |
| ovary | 10% | 2.10 | 18 / 180 | 52% | 1.86 | 224 / 430 |
| lung | 37% | 11.16 | 213 / 578 | 24% | 0.60 | 275 / 1155 |
| stomach | 24% | 9.86 | 85 / 359 | 23% | 0.65 | 67 / 286 |
| blood vessel | 36% | 10.99 | 487 / 1335 | 0% | 0 | 0 / 0 |
| breast | 15% | 2.86 | 71 / 459 | 20% | 0.52 | 219 / 1118 |
| pancreas | 12% | 2.44 | 40 / 328 | 19% | 0.40 | 33 / 178 |
| thymus | 5% | 1.91 | 31 / 653 | 24% | 0.54 | 147 / 605 |
| lymph node | 0% | 0 | 0 / 0 | 21% | 0.56 | 6 / 29 |
| muscle | 21% | 4.80 | 166 / 803 | 0% | 0 | 0 / 0 |
| spleen | 15% | 2.51 | 35 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 10% | 1.78 | 94 / 929 | 0% | 0 | 0 / 0 |
| adipose | 9% | 2.20 | 104 / 1204 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 7% | 0.23 | 3 / 45 |
| eye | 0% | 0 | 0 / 0 | 6% | 0.09 | 5 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0017015 | Biological process | regulation of transforming growth factor beta receptor signaling pathway |
| GO_0001837 | Biological process | epithelial to mesenchymal transition |
| GO_0007179 | Biological process | transforming growth factor beta receptor signaling pathway |
| GO_0016477 | Biological process | cell migration |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0050431 | Molecular function | transforming growth factor beta binding |
| GO_0005539 | Molecular function | glycosaminoglycan binding |
| GO_0005024 | Molecular function | transforming growth factor beta receptor activity |
| GO_0005114 | Molecular function | type II transforming growth factor beta receptor binding |
| Gene name | TGFBR3L |
| Protein name | Transforming growth factor-beta receptor type 3-like protein (TGF-beta receptor type-3-like protein) (TGFR-3L) (Transforming growth factor-beta receptor type III-like protein) (TGF-beta receptor type III-like protein) |
| Synonyms | |
| Description | FUNCTION: Expressed in gonadotrope cells, acts as an inhibin B coreceptor and regulates follicle-stimulating hormone (FSH) levels and female fertility. . |
| Accessions | ENST00000565886.2 [H3BV60-2] H3BV60 |